The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Kailash Shantilal Choudhari
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Kailash Shantilal Choudhari, Promoter and Director of Aksh Optifibre Ltd, has disclosed a sale of 42,849 equity shares (0.03% of the paid-up share capital) through the open market on May 29 and May 30, 2025. Following this sale, his individual holding in the company has reduced marginally from 5.59% (90,95,717 shares) to 5.56% (90,52,868 shares). The disclosure was filed under Regulation 29(2) of the SEBI Takeover Regulations, which mandates promoters to report changes in their shareholding. The total promoter group holding, including persons acting in concert, stands at 9.41% as per the annexure.
This is a very small, routine sale by the promoter with negligible impact on shareholding pattern or stock price. The promoter group's overall stake remains well below 50%, so there is no change in control implications for shareholders.